CholBiome®BP is a supplement formulated to improve blood pressure, containing the patented LPLDL probiotic strain, Thiamine, L-arginine and Co-enzyme Q10
The aim of this study was to investigate the blood pressure reduction capabilities (both systolic and diastolic) of CholBiomeBP in patients with high normal blood pressure.
A daily dose of CholBiomeBP was completely safe and well tolerated and showcased statistically significant results on blood pressure.
The study carried out by the University of Pavia confirmed the formulation containing LPLDL, L-arginine, Thiamine and Co-Enzyme Q10 (CholBiomeBP) demonstrated statistically significant improvements on high-normal blood pressure and hypercholesterolemia.
Conflict of interest
The authors declare no conflict of interest. This human intervention study was funded by OptiBiotix health PLC and carried out independently by the University of Pavia.